Search

everythinglearnresearchcommunity

for

Search:↓

Current corticosteroid pulse therapy is not very effective for severe rapidly progressive alopecia areata.

The drug combination was safe and showed promise in treating advanced tumors.

Treat limited stage small cell lung cancer with chemotherapy and radiation, and consider preventive brain radiation for better survival chances.

MK-5108 is safe and shows potential against tumors, especially alone.

Regulatory measures are needed to ensure safe production and use of platelet concentrates in Brazil.

Tofacitinib is a promising treatment for children with rheumatic diseases.

The treatment was effective and tolerable for advanced gastric cancer.

Amyloid proteins can cause rare hair loss by depositing in the scalp.

Excimer light effectively treats various skin diseases, including psoriasis, vitiligo, and mycosis fungoides.

Tofacitinib is somewhat effective for alopecia areata, but more research is needed on its safety and long-term effects.

The critique highlights an error in a review about hair loss treatment, stressing the need for accurate information and caution due to poor evidence quality.

PRP treatment may help with alopecia areata, especially in newer cases.

The study found that severe alopecia areata affects any age, treatments often give temporary results, and some factors predict worse outcomes.

1% anthralin ointment is effective and safe for treating severe alopecia areata in children.

The oral contraceptive alone is the preferred treatment for hirsutism, as adding the GnRH analog showed no significant benefit.

A man's scalp condition was misidentified as hair loss dots but was actually a common follicular disorder.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

Baricitinib helped some patients with tough-to-treat hair loss regrow hair, but more research is needed on its safety.

Lichen planopilaris can cause patchy hair loss in children and may respond to certain treatments.

Tildrakizumab showed limited effectiveness in treating chronic alopecia areata in a small group of patients.

Further testing of paclitaxel poliglumex for this cancer treatment is not justified.

Disitamab vedotin and gemcitabine effectively treated bladder cancer without major side effects.

Paclitaxel and nab-paclitaxel can be safe and effective for advanced gastric cancer patients on hemodialysis.

Low-dose intermittent corticosteroid therapy can effectively treat alopecia areata.

CVP therapy showed moderate success in treating advanced non-Hodgkin's lymphoma, but more intensive treatment is needed for better outcomes.

Lighter skin types respond better to narrowband UVB therapy for cutaneous T-cell lymphoma than darker skin types.

Selumetinib effectively reduces tumor size in many children with neurofibromatosis type 1, but can cause skin and hair issues.

The case suggests that dissecting cellulitis of the scalp can occur in a White child and should be considered when diagnosing pediatric scarring alopecia.

The conclusion is that different treatments improved hair growth in dogs with Alopecia X, but results varied and not all dogs had complete hair regrowth.

Stem cell serum effectively treated hair loss caused by COVID-19.